2023 PM Society Awards – Winners Announced
21GRAMS takes four Golds plus Best in Show AstraZeneca tops the pharma leader board
24th March 2023
21GRAMS takes four Golds plus Best in Show AstraZeneca tops the pharma leader board
24th March 2023
Study shows significant reduction of nasal S. aureus in cardiac surgery patients before surgery
24th March 2023
The multi-centre international clinical trial will evaluate company’s Debio 0328 candidate
24th March 2023
The partnership will involve progressing macrophage-targeting antibody treatment for cancer
23rd March 2023
Eladocagene exuparvovec is for children with ultra-rare genetic disorder in final draft guidance
23rd March 2023
PharmaTimes’ Editor John Pinching talks to AstraZeneca’s inspiring diversity and inclusion leader for Europe and Canada, Anna-Lena Engwall
England’s prescribing trends provide a host of intriguing insights
Digging deep into the maelstrom of intellectual property in pharma
Data quality governance – dispelling five common myths
How can we use precision medicine to improve heart failure care?
We must look after an entire nation’s health – regardless of wealth
Pharmacy’s central role in women’s health – including the menopause – must reflect a more modern, tailored approach
As the NHS remains in intensive care, its long-term future is shrouded in doubt
Leading pharma companies are setting targets for reducing their greenhouse gas emissions, and reporting on their progress in meeting them. That’s according to a new study we at Oxford PharmaGenesis conducted in collaboration with researchers from the University of Oxford. But when it comes to reporting on supply chain emissions, more collaboration is needed – and the time is now.
The NHS faces many challenges when it comes to service efficiencies
Professor Gino Martini, CEO of the Precision Health Technologies Accelerator (PHTA Ltd), explains how Birmingham is providing the collaborative space to simultaneously drive innovation in pharma, and tackle health inequality.
Post-pandemic, we have been forced to rethink the way in which medicines information is disseminated and consumed.
Thursday, 23 June 2022 - 3:00 pm
COVID-19 has had a huge impact on how we all think and act. Our working environments may look very different now to the way they did pre-pandemic, and not all the changes have been negative.
Andrés López Castaño, Tricia Lucas-Clarke, Noor Shaker, Sandra Van de Cauter, Marsha N. Ganthier
FREE | REGISTER NOW
Tuesday, 22 February 2022 - 4:00 pm
With Tufts reporting that the average number of patient dropouts for clinical trials remains near 30%, it is clear that there is still much to be done towards improving retention¹.
Andrew Mackinnon, Digital Trial Operations Lead, Medable
FREE | ATTEND
Wednesday, 21 July 2021 - 2:00 pm
In healthcare, the patient voice is arguably the most important. Services and care work best when a person’s needs are fully met and they feel heard, respected and valued.
Mark Doyle, co-founder of The Method and creator of A Life in a Day
FREE | ATTEND
Wednesday, 28 September 2016 - 11:00 am
Across all industries, people are changing the ways they engage with products, services, and brands.
George Underwood
FREE - Listen again now - | VIEW NOW